Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > CELG > Summary

Celgene Corporation
(CELG)

55.50USD   Up0.73 (1.33%)   
At 2:30AM IST
 Celgene Corporation (NasdaqNM:CELG) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 55.50USD
Trade Time:2:30AM IST
Change:Up0.73 (1.33%)
Prev Close:54.77
Open:55.69
Bid:55.50 x 100
Ask:55.97 x 300
1y Target Est:65.15
Day's Range:55.01 - 56.33
52wk Range:36.90 - 59.67
Volume:2,926,769
Avg Vol (3m):3,835,570
Market Cap:25.51B
P/E (ttm):69.20
EPS (ttm):0.80
Div & Yield:N/A (N/A%)
Add CELG to Portfolio   Download Data

HEADLINES

 
•You'll Become a Millionaire -- Here's When - Motley Fool  - Mon, Feb 8
•The Stocks With the Most Potential - Motley Fool  - Fri, Feb 5
•Onyx and FDA agree on cancer drug study design - AP  - Tue, Feb 2
•In Cautionary Mode: Overweight Tech, Healthcare, Consumer Staples, Emerging /Frontier Markets - Seeking Alpha  - Tue, Feb 2
•'Fast Money' Recap: Rally Worries - TheStreet.com  - Tue, Feb 2
•Big Week For Pharma - CNBC  - Tue, Feb 2
•New Star Analyst Rankings for Celgene Corporation - StarMine  - Sat, Jan 30
•Loosen Up, Tightwads! - Barrons.com  - Sat, Jan 30
•Wake Up! You Still Have to Pay Attention - Motley Fool  - Sat, Jan 30
•Celgene Beats Zacks Estimate - Zacks.com  - Fri, Jan 29
•1-Star Stocks Poised to Plunge: Cytori Therapeutics? - Motley Fool  - Fri, Jan 29
•Celgene Corporation Q4 2009 Earnings Call Transcript - Seeking Alpha  - Fri, Jan 29
» More Headlines for CELG...

ANALYST

 
EPS Est (next year) (Dec-09) :2.08
EPS Est (in 2 years) (Dec-10) :2.63
Avg Rec (current)*:2.0
PEG Ratio:1.15
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Celgene Corporation engages in the discovery, development, and commercialization of innovative therapies to treat cancer and immune-inflammatory related diseases primarily in Europe and the United States.

» Full Company Profile